$ACT Headlines Pfizer's plan to relocate after merger

New Post Public Reply Private Reply Replies (0) Message Board

May 13, 2014 at 10:29 AM

$ACT Headlines

Pfizer's plan to relocate after merger deal draws lawmakers' fire 11:30 a.m. May 9, 2014 - blogs.marketwatch.com
Corner drug store may move overseas to save on taxes 6:30 a.m. April 16, 2014 - Al Lewis
Intuitive Surgical slumps; Facebook extends rally 3:41 p.m. April 9, 2014 - Saumya Vaishampayan
Actavis acquires Silom Medical for $100 million 10:19 a.m. April 1, 2014 - MarketWatch.com
The 10 most overbought stocks in the S&P 500 index 12:19 p.m. March 25, 2014 - The Trading Deck
UK drug rejection, patent concerns take a bite out of Celgene shares 1:33 p.m. March 14, 2014 - blogs.marketwatch.com
Mylan to start selling generic Celebrex in May 7:22 a.m. March 13, 2014 - MarketWatch.com
Pfizer loses Celebrex patent ruling; shares halted but effect muted 3:21 p.m. March 12, 2014 - blogs.marketwatch.com
Staples awash in red; eBay up as Icahn posts new letter 4:09 p.m. March 6, 2014 - Victor Reklaitis
Icahn Enterprises reports profit up 144% in 2013 10:22 a.m. March 3, 2014 - MarketWatch
Citadel hedge fund’s recent moves 11:12 a.m. Feb. 25, 2014 - Insider Monkey
Stocks rally; S&P 500 ends right below record 4:45 p.m. Feb. 24, 2014 - Victor Reklaitis
U.S. stock market is starting to ride a tech M&A wave 5:31 a.m. Feb. 24, 2014 - Wallace Witkowski
Actavis continues hot streak with better-than-expected earnings 11:21 a.m. Feb. 20, 2014 - blogs.marketwatch.com
Actavis swings to loss on charges, write-downs 8:03 a.m. Feb. 20, 2014 - MarketWatch.com
Pharma megamergers bring higher profits, better returns, study says 1:59 p.m. Feb. 19, 2014 - blogs.marketwatch.com
Actavis, Forest shares continue their climb in aftermath of $25 billion deal 11:03 a.m. Feb. 19, 2014 - blogs.marketwatch.com
U.S. stocks edge up; Nasdaq gains for 8th day in a row 4:38 p.m. Feb. 18, 2014 - Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal 4:10 p.m. Feb. 18, 2014 - Ben Eisen
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap 4:06 p.m. Feb. 18, 2014 - blogs.marketwatch.com

Cross-Border Megamergers Drive Global Takeover Boom 4:01 p.m. May 12, 2014 - Investors Business Daily
3 Drugs Stocks On The Rise 1:02 p.m. May 12, 2014 - TheStreet.com
Actavis and Valeant settle patent fight 8:26 a.m. May 12, 2014 - Seeking Alpha
The 'Inversion' Premium 7:29 p.m. May 11, 2014 - The Wall Street Journal Interactive Edition
Vivus Discloses Competitive Threat 10:51 a.m. May 10, 2014 - Seeking Alpha
M.D. Sass: Bullish on Broadcast, Health Care 3:26 a.m. May 10, 2014 - Barrons.com
Acorda Misses on Earnings, Beats Revs - Analyst Blog 1:43 p.m. May 7, 2014 - Zacks.com
3 Drugs Stocks Dragging The Industry Down 1:03 p.m. May 7, 2014 - TheStreet.com
What Does Celgene's May 15 Markman Hearing Mean to You? 10:11 a.m. May 7, 2014 - TheStreet.com
Actavis, Michael Kors Among World Stocks Near Buy Points 5:50 p.m. May 6, 2014 - Investors Business Daily
10-Q: ACTAVIS PLC 5:15 p.m. May 5, 2014 - Edgar Online - (EDG = 10Q, 10K)
Hottest Healthcare Stocks Now – HMSY ACAD ACT MWIV 1:45 p.m. May 5, 2014 - InvestorPlace.com
Best Five Stocks Over $100 10:07 a.m. May 3, 2014 - 247WallSt.com
AstraZeneca Nixes New Bid As Pfizer Woos British PM 1:11 p.m. May 2, 2014 - Investors Business Daily
Earnings Beat at Endo, Shares Up on Improved Outlook - Analyst Blog 12:10 p.m. May 2, 2014 - Zacks.com
Tyco Eyes 'Business Friendly' Ireland 8:35 a.m. May 2, 2014 - The Wall Street Journal Interactive Edition
What's With All The Healthcare And Pharmaceutical Mergers? 5:25 p.m. May 1, 2014 - TheStreet.com
Avanir Wins Lawsuit, Shares Up - Analyst Blog 4:39 p.m. May 1, 2014 - Zacks.com
A Look At World Stocks' Q1: Shire, Actavis, NXP Semi 4:32 p.m. May 1, 2014 - Investors Business Daily
Mylan Beats on Earnings, Misses on Sales - Analyst Blog 1:17 p.m. May 1, 2014 - Zacks.com

Actavis Announces Acanya® Gel Patent Challenge Settlement 8:00 a.m. May 12, 2014 - PR Newswire - PRF
Technical Coverage on Pharma Equities -- Research on Allergan, Actavis, Medicines Co., and Akorn 11:30 a.m. May 9, 2014 - PR Newswire - PRF
Actavis Launches Generic Version of Catapres-TTS® 4:05 p.m. May 7, 2014 - PR Newswire - PRF
Financial Results, Study Results, and Conference Schedules - Analyst Notes on Actavis, BMS, Baxter, Biogen Idec and AbbVie 9:00 a.m. May 6, 2014 - PR Newswire - PRF
Actavis and Forest Announce Effectiveness of Registration Statement on Form S-4 9:02 a.m. May 5, 2014 - BusinessWire - BZX
Actavis and Forest Announce Effectiveness of Registration Statement on Form S-4 9:00 a.m. May 5, 2014 - PR Newswire - PRF
Pfizer Expects $100 Billion Grab for AstraZeneca to Boost Pipeline and Drop Tax Rate, an Industrial Info News Alert 6:31 a.m. April 30, 2014 - Marketwire
Stocks Close to Reporting their Earnings -- Research on Actavis, NYSE Community Bancorp, Hess, and Dominion Resources 4:36 a.m. April 30, 2014 - PR Newswire - PRF
Actavis Sues FDA Regarding Delay of Generic Celebrex® Approval 5:14 p.m. April 28, 2014 - PR Newswire - PRF
Strategic Collaborations, Fresh Agreements, and Upcoming Conferences - Analyst Notes on Biogen, Bristol-Myers, AbbVie, Actavis and Bard 8:00 a.m. April 28, 2014 - PR Newswire - PRF
Stockholder Rights Plan, Quarterly Results, Clinical Trial Results, Purchase Agreements, and New Contracts - Analyst Notes on Allergan, Gilead, Pfizer, Actavis and Express Scripts 8:00 a.m. April 25, 2014 - PR Newswire - PRF
Actavis Announces Celebrex® Patent Challenge Settlement 9:20 a.m. April 24, 2014 - PR Newswire - PRF
Actavis Announces Departure of G. Frederick Wilkinson, President, Actavis Global R&D 9:03 a.m. April 21, 2014 - PR Newswire - PRF
Actavis to Acquire Four Products from Akorn 4:15 p.m. April 17, 2014 - PR Newswire - PRF
Actavis and Forest Laboratories Receive FTC Second Request Under Hart-Scott-Rodino 4:05 p.m. April 17, 2014 - BusinessWire - BZX
Actavis and Forest Laboratories Receive FTC Second Request Under Hart-Scott-Rodino 4:05 p.m. April 17, 2014 - PR Newswire - PRF
Actavis Announces Agreement Related to Generess® FE Patent Challenge Litigation 8:00 a.m. April 15, 2014 - PR Newswire - PRF
Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement Grants, and Clinical Trial Results - Analyst Notes on Actavis, The Medicines Company, Hospira, Horizon Pharma, and Galectin 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Pharma Equities under Review -- Research on Mylan, Actavis, Hospira, and Medicines 12:30 p.m. April 10, 2014 - PR Newswire - PRF
Actavis Launches Asia Pacific Regional Headquarters in Singapore 8:00 p.m. April 2, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

viaim's AI Earbuds Snag IFA Awards, Launch On Indiegogo

When the tech cosmos hands you two hefty IFA Innovation Awards, you know you’re onto something. viaim’s Rise wasn't just about slick marketing—it brought home the 'Best in Audio' and 'Best in Design' titles from IFA 2026, proving these earbuds are more than just another gadget. Key Innovations Behind the Accolades IFA is no small affair—it's a major tech trade...

Why Buyers Are Flocking to Whidbey Island Homes

Something's got folks eyeing Whidbey Island like a gambler with a hot tip—and it ain't just the thrill of a vacation spot. Anyone with half a brain knows real estate moves in waves, and right now, Whidbey Island's caught some serious momentum. You can't ignore the pull of natural beauty, access to city life, and that laid-back vibe that seems to whisper "slow down and...

Dreame Unveils Vast AI Product Range at IFA 2026

Overnight Sensation or Future Staple? I wonder if Dreame's top brass woke up sweating or smiling after their big reveal at IFA 2026. A buffet of over 100 products across 16 categories is no small feat, especially when you're banking on technologies developed over nine years. But let's cut through the noise—does this showcase promise innovation or just smoke and mirrors?...

Morpho Unveils Versatile UV Printer at IFA 2026

IFA 2026: A New Frontier for Desktop Printing You've seen your fair share of printers over the years, but when a company like Morpho steps onto the scene with a gadget that echoes innovation, it makes you perk up those market-ears. We're talking the big unveil of their desktop UV printer at the IFA 2026 in Berlin. Morpho's contraption isn't just spewing out ink; it's...

Nocpix's Evolution: New Thermal Riflescope Unveiled

Raising the Thermal Image Bar When Nocpix, known for cutting-edge electro-optical tech, teases a new thermal riflescope, it's time for hunters to perk up. This ain't just another gadget. We're talking about equipment that elevates precision and brings an edge to the field. Scheduled for hunters who mean business, this next-gen scope is destined to redefine what it means...

Hims & Hers Faces Legal Storm Over Alleged Privacy Breaches

Legal Storms Brew Over Alleged Privacy Breaches Well, here we go again, folks. Just when you think the waters are calming, Hims & Hers Health, Inc. (NYSE: HIMS) finds itself in the thick of a nasty securities fraud class action lawsuit. Allegedly they've been less than honest with their customers' health info—something about sneaking around with people's sensitive data...

Pudu D7 Robot Shines at IFA, Setting New Robotics Bar

Breaking New Ground in Robotics at IFA Well, here's a nugget for robotics buffs and investors alike: Pudu Robotics, a heavyweight in commercial service robotics, is carving out a fresh chapter with its PUDU D7. Making waves as an honoree at the IFA Innovation Awards, the D7 presents a mash-up of brains and brawn—exemplifying the future path for robotics. The PUDU D7...

Unlocking Insights: South Chicagoland Home Inspections

Sizing Up South Chicagoland Homes: What Really Gets Inspected In the world of real estate transactions, home inspections stand like grizzled veterans, proudly scrutinizing every nook and cranny before the ink dries on a property deed. Here in South Chicagoland, where the echoes of every frigid winter and sweltering summer linger, the process becomes a lifeline for buyers...

D-Wave Hit with Legal Scrutiny After Disappointing Q2

D-Wave Quantum Under Legal Microscope Alright, folks, let's dive headfirst into some dicey financial waters with D-Wave Quantum Inc. (NASDAQ: QBTS). This quantum computing company is finding itself in a bit of a pickle following some rough second-quarter results that left investors scratching their heads. If you bought into the hype and are feeling the sting in your...

LiberNovo Demos Ergonomic Seating at IFA 2026

Riding the Ergonomic Wave at IFA 2026 No stranger to the innovation spotlight, LiberNovo’s got its eyes on Berlin this time around. As sparks fly at the IFA 2026, they’re rolling out their grand Maxis Series and rubbing shoulders with big names in technology. How does a company shake things up in a sea of tech? Start by thinking big and tall—literally. Maxis Series:...